Long-term efficacy, safety, tolerability and quality of life with fingolimod treatment in patients with multiple sclerosis in real-world settings in France: VIRGILE study design

被引：0

作者：

Coustans, M. ^{[1
]}

Debouverie, M. ^{[2
]}

Kobelt, G. ^{[3
]}

Lebrun-Frenay, C. ^{[4
]}

Leray, E. ^{[5
]}

Papeix, C. ^{[6
]}

Visy, J. M.

Willemin, L. ^{[7
]}

Allaf, B. ^{[7
]}

机构：

[1] Laenneck Hosp, Quimper, France

[2] Cent Hosp, Nancy, France

[3] France Lund Univ Sweden, Speracedes, France

[4] Pasteur Hosp, Nice, France

[5] EHESP Sorbonne Paris Cite, Paris, France

[6] La Salpetriere Hosp, Paris, France

[7] Novartis Pharma SAS, Paris, France

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EP1464

引用

页码：764 / 764

页数：1